Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹7 Cr
P/E Ratio
139.02
P/B Ratio
1.02
Industry P/E
41.39
Debt to Equity
0.21
ROE
0.78 %
ROCE
3.16 %
Div. Yield
0 %
Book Value
13.3
EPS
0.1
CFO
₹-2.39 Cr
EBITDA
₹2.08 Cr
Net Profit
₹0.77 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Ganga Pharma
| -- | 46.05 | -20.53 | -- | -- | -- | -- |
|
BSE Healthcare*
| -6.41 | 2.05 | 1.56 | 18.86 | 20.20 | 22.34 | 10.10 |
|
BSE Small Cap#
| -12.67 | 2.60 | -2.47 | 1.22 | 18.70 | 34.24 | 15.88 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2,151.10 | 5,411.31 | 78.19 | 43.52 | |
| 360.00 | 407.72 | 598.71 | 1.68 | |
| 144.10 | 227.59 | 36.09 | 99.24 | |
| 131.00 | 137.73 | 69.55 | 4.82 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1989
Chairman
Sanjay Vyankatesh Kulkarni
Managing Director
Bharat Brijmohan Sharma
Headquarters
Palghar, Maharashtra
Website
Looking for more details about Ganga Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Ganga Pharmaceuticals Ltd stood at ₹ 9 Cr as on 31-Mar-24
The share price of Ganga Pharmaceuticals Ltd is ₹13.51 (BSE) as of 22-Apr-2025 IST. Ganga Pharmaceuticals Ltd has given a return of --% in the last 1 years.
Ganga Pharmaceuticals Ltd has a market capitalisation of ₹ 7 Cr as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Ganga Pharmaceuticals Ltd is 1.02 times as on 22-Apr-2025, a 76% discount to its peers’ median range of 4.22 times.
The P/E ratio of Ganga Pharmaceuticals Ltd is 139.02 times as on 22-Apr-2025, a 236% premium to its peers’ median range of 41.39 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Ganga Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Ganga Pharmaceuticals Ltd.
Manufacture of allopathic pharmaceutical preparations
The prominent promoters of Ganga Pharmaceuticals Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
SHARMA BHARAT B |
30.12%
|
|
BRIJMOHAN SHARMA HUF |
7.23%
|
|
ANAGH BHARAT SHARMA |
5.38%
|
The chairman of the company is Sanjay Vyankatesh Kulkarni, and the managing director is Bharat Brijmohan Sharma.
There is no promoter pledging in Ganga Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
5,345
|
|
|
413
|
|
|
237
|
|
|
146
|
| Ganga Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.78
|
|
Operating margin(%)
|
0.31
|
|
Net Margin(%)
|
1.57
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Ganga Pharmaceuticals Ltd was ₹0 Cr.
₹1.22
(
